| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |